From the CEO's AGM Presentation (page 6) - Delivery against 2018 Objectives:
_________
DX1 – TNBC brain metastases animal data
Q4 2018
DX1 – Additional solid cancer (TBC) animal data
Q1 2019
DX1 + radiation – brain cancer animal data
Q4 2018/Q1 2019
_________
From the CEO's AGM Presentation (Page 22) - Looking Ahead:
_________
DX1 + radiation – brain cancer animal data
Q4 2018/Q1 2019
DX1 – solid cancer (TBC) animal data
Q1 2019
DX1 + temazolamide – brain cancer animal data
Q1 2019
________
Comment: A couple of differences there. A far cry from the mid year and more straightforward
Aug 2018 - Solid cancer animal data
Oct 2018 - Additional solid cancer animal data
(neither of which materialised).
Also, wonder what happened to the provision of 'more complete pharmacokinetic profiling' (ann of 05-07-2018).
Sometimes silence is not golden. Easy to conclude things are not going exactly to plan.
- Forums
- ASX - By Stock
- PAB
- Ann: Chairman's Address and CEO Presentation to 2018 AGM
Ann: Chairman's Address and CEO Presentation to 2018 AGM, page-51
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
-0.001(14.3%) |
Mkt cap ! $12.34M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $518 | 86.30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 705914 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1128726 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 705914 | 0.006 |
15 | 7449991 | 0.005 |
11 | 6764199 | 0.004 |
6 | 6065682 | 0.003 |
2 | 2770000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1128726 | 3 |
0.008 | 2061233 | 5 |
0.009 | 431000 | 1 |
0.010 | 396000 | 5 |
0.011 | 680000 | 2 |
Last trade - 15.42pm 02/09/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |